Target Price | JPY7,596.15 |
Price | JPY6,625.00 |
Potential |
14.66%
register free of charge
|
Number of Estimates | 13 |
13 Analysts have issued a price target Chugai Pharmaceutical 2026 .
The average Chugai Pharmaceutical target price is JPY7,596.15.
This is
14.66%
register free of charge
JPY9,900.00
49.43%
register free of charge
JPY5,300.00
20.00%
register free of charge
|
|
A rating was issued by 15 analysts: 7 Analysts recommend Chugai Pharmaceutical to buy, 8 to hold and 0 to sell. | |
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
Analyst Estimates: Analysts believe that the Chugai Pharmaceutical stock has an average upside potential 2026 of
14.66%
register free of charge
|
Dec '24 |
2025 Estimates |
|
---|---|---|
Revenue Billion JPY | 1,170.61 | 1,186.86 |
5.33% | 1.39% | |
EBITDA Margin | 48.81% | 49.18% |
21.24% | 0.77% | |
Net Margin | 33.09% | 34.41% |
12.96% | 3.99% |
14 Analysts have issued a sales forecast Chugai Pharmaceutical 2025 . The average Chugai Pharmaceutical sales estimate is
This results in the following potential growth metrics:
7 Chugai Pharmaceutical Analysts have issued a net profit forecast 2025. The average Chugai Pharmaceutical net profit estimate is
This results in the following potential growth metrics and future Net Margins:
Dec '24 |
2025 Estimates |
|
---|---|---|
Earnings Per Share JPY | 235.39 | 248.16 |
18.99% | 5.43% | |
P/E | 26.81 |
7 Analysts have issued a Chugai Pharmaceutical forecast for earnings per share. The average Chugai Pharmaceutical <a href=https://blog.stocksguide.com/knowledge/eps-simply-explained>EPS is
This results in the following potential growth metrics and future valuations:
Chugai Pharmaceutical...
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.